Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
Adult
Antibodies, Viral
Biomarkers
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
COVID-19
/ diagnosis
Enzyme-Linked Immunosorbent Assay
Epitopes, T-Lymphocyte
/ chemistry
Female
Health Personnel
Humans
Immunophenotyping
Lymphocyte Activation
/ immunology
Male
Middle Aged
Peptides
/ chemistry
Public Health Surveillance
SARS-CoV-2
/ immunology
Seroepidemiologic Studies
Severity of Illness Index
Spike Glycoprotein, Coronavirus
/ immunology
T-Lymphocyte Subsets
/ immunology
COVID-19
SARS-CoV-2
T cells
coronaviruses
health care workers
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
02 07 2021
02 07 2021
Historique:
received:
17
02
2021
accepted:
30
03
2021
pubmed:
7
4
2021
medline:
20
7
2021
entrez:
6
4
2021
Statut:
ppublish
Résumé
Herein we measured CD4+ T-cell responses against common cold coronaviruses (CCC) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in high-risk health care workers (HCW) and community controls. We observed higher levels of CCC-reactive T cells in SARS-CoV-2-seronegative HCW compared to community donors, consistent with potential higher occupational exposure of HCW to CCC. We further show that SARS-CoV-2 T-cell reactivity of seronegative HCW was higher than community controls and correlation between CCC and SARS-CoV-2 responses is consistent with cross-reactivity and not associated with recent in vivo activation. Surprisingly, CCC T-cell reactivity was decreased in SARS-CoV-2-infected HCW, suggesting that exposure to SARS-CoV-2 might interfere with CCC responses, either directly or indirectly. This result was unexpected, but consistently detected in independent cohorts derived from Miami and San Diego. CD4+ T-cell responses against common cold coronaviruses (CCC) are elevated in SARS-CoV-2 seronegative high-risk health care workers (HCW) compared to COVID-19 convalescent HCW, suggesting that exposure to SARS-CoV-2 might interfere with CCC responses and/or cross-reactivity associated with a protective effect.
Identifiants
pubmed: 33822097
pii: 6209393
doi: 10.1093/infdis/jiab176
pmc: PMC8083569
doi:
Substances chimiques
Antibodies, Viral
0
Biomarkers
0
Epitopes, T-Lymphocyte
0
Peptides
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
70-80Subventions
Organisme : NIAID NIH HHS
ID : R25 AI147376
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI141995
Pays : United States
Organisme : University of Miami Institutional Support
Organisme : Open Philanthropy Project
ID : 2020-215611
Organisme : NIAID NIH HHS
ID : R01 AI135193
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG068110-01A1
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00051
Pays : United States
Organisme : Miami Clinical and Translational Science Institute Emerging Disease Proposal
Organisme : NCI NIH HHS
ID : U01 CA260541
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI142742
Organisme : NIH HHS
ID : 75N9301900065
Pays : United States
Organisme : JPB Foundation
Organisme : NIA NIH HHS
ID : R01 AG068110
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI142742
Pays : United States
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
BMC Infect Dis. 2019 Jun 3;19(1):491
pubmed: 31159777
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Health Secur. 2021 Mar-Apr;19(2):195-208
pubmed: 33186086
J Infect Dis. 2021 Jan 4;223(1):56-61
pubmed: 33128369
Am J Infect Control. 2009 Jun;37(5):417-419
pubmed: 19216002
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Front Immunol. 2020 Oct 15;11:567710
pubmed: 33178193
J Immunol. 2005 Jul 1;175(1):591-8
pubmed: 15972696
Cell Rep Med. 2021 Feb 16;2(2):100204
pubmed: 33521695
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Int J Infect Dis. 2021 Jan;102:63-69
pubmed: 33075539
BMC Pulm Med. 2020 Jul 29;20(1):203
pubmed: 32727446
Front Immunol. 2020 Oct 16;11:586984
pubmed: 33178220
J Clin Virol. 2018 Apr;101:52-56
pubmed: 29427907
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 32997649
BMC Infect Dis. 2018 Apr 17;18(1):184
pubmed: 29665775
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Clin Microbiol Infect. 2020 Dec;26(12):1670-1675
pubmed: 32911080
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
PLoS Pathog. 2019 Jan 24;15(1):e1007474
pubmed: 30677097
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
JAMA. 2020 Sep 1;324(9):893-895
pubmed: 32780804
Curr Protoc Microbiol. 2020 Jun;57(1):e100
pubmed: 32302069
J Virol. 2020 May 4;94(10):
pubmed: 32132233
J Virol. 2014 Oct;88(19):11034-44
pubmed: 25056892
J Clin Invest. 2018 Aug 31;128(9):3853-3865
pubmed: 29920186
J Immunol. 2013 Sep 1;191(5):2486-94
pubmed: 23885108
Immunity. 2020 Dec 15;53(6):1258-1271.e5
pubmed: 33296686
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
J Immunol Res. 2015;2015:763461
pubmed: 26568965
J Virol. 2003 Jan;77(1):68-76
pubmed: 12477811
Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2
pubmed: 32183941
PLoS One. 2017 Jan 12;12(1):e0169086
pubmed: 28081174
Nat Rev Immunol. 2020 Nov;20(11):709-713
pubmed: 33024281
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33216734
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
J Clin Invest. 2020 Dec 1;130(12):6631-6638
pubmed: 32966269
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Immunity. 2021 Feb 9;54(2):340-354.e6
pubmed: 33567252
J Infect Dis. 2020 Jun 16;222(1):17-25
pubmed: 32296837